Viewing nowLipitor Tablet 40 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
Korea Shintec Pharmaceutical Co., Ltd.

MFDS item code 201804838 · Approved 2018.11.30 · Insurance code 623005130
Improvement of hyperlipidemia; prevention of cardiovascular diseases such as myocardial infarction and stroke
This medication helps reduce the risk of myocardial infarction and stroke in adult patients at high risk for cardiovascular disease, especially those with risk factors for coronary artery disease. It is also effective in reducing the risk of myocardial infarction and stroke in patients with type 2 diabetes who have cardiovascular risk factors. It is used to lower the risk of hospitalization for non-fatal myocardial infarction, stroke, angina, and congestive heart failure in patients with clinically documented heart disease. Additionally, this medication serves as an adjunct therapy to improve cholesterol and triglyceride levels in patients with hyperlipidemia and to increase HDL cholesterol levels. It is particularly useful for patients with various dyslipidemias who do not respond to standard dietary therapy, as well as for patients with familial hypercholesterolemia who are difficult to treat. Overall, it is effectively used to improve cardiovascular health and regulate lipid levels.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken once daily at any time of day, with or without food. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation and/or dose titration, and the dose adjusted accordingly. Since the aim of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in adult patients.
This medication may cause muscle problems, so if you experience muscle pain or weakness, you should inform your doctor immediately. Patients with impaired liver function or a history of liver disease should consult a doctor before taking this medication. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication, and women of childbearing age should use proper contraceptive methods while taking it. This medication may increase the risk of side effects when taken with certain other medications, so inform your doctor or pharmacist of any current medications you are taking. Children, especially those under 10 years old, should not take this medication, and children over 10 should follow their doctor's instructions. Elderly patients may be at higher risk of muscle-related side effects, so caution is advised during use, and regular check-ups are recommended. Severe skin rash or allergic reactions may occasionally occur, so if these symptoms arise, discontinue use immediately and consult medical personnel. There is no specific antidote for overdose, so care should be taken not to exceed the recommended dosage, and if suspected, seek medical attention promptly. This medication should be stored in its original container and kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and at room temperature, ideally between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy and ensures safe use.
White oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.38mg
Tablet · Prescription medication
Korea Shintec Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.